Company: ARTL
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001640334-25-000825
Chunk: 202

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-05-13
Form: 10-Q
Item: Part I, Item 2
Chunk 202
---
ical Cash Flows

The following table summarizes our cash flows for the periods indicated:

  Three months ended      March 31,    (In thousands) 2025  2024  Change Cash Flows used in operating activities $(1,597) $(2,942) $1,345 Cash Flows provided by investing activities  -   1,269   (1,269)Cash Flows provided by financing activities  -   55   (55)Effect of exchange rate changes on cash  5   (2)  7 Net change in cash and cash equivalent during period $(1,592) $(1,620) $28 

Cash Flows from Operating Activities

During the three months ended March 31, 2025, cash used in operating activities was $1.6 million compared to $2.9 million during the three months ended March 31, 2024. Cash used in operating activities during the three months ended March 31, 2025, was attributed to a net loss of $2.4 million offset by decreases in operating assets and liabilities of $0.6 million and non-cash stock-based compensation of $0.2 million. Cash used in operating activities during the three months ended March 31, 2024, was attributed to a net loss of $2.5 million and a non-cash gain of $0.1 million associated with our trading of marketable securities and decreases in operating assets and liabilities of $0.6 million offset by stock-based compensation of $0.2 million.

Cash Flows from Investing Activities

During the three months ended March 31, 2025, cash provided by investing activities was $0.0 million compared to $1.3 million during the three months ended March 31, 2024. During the three months ended March 31, 2024, cash flows provided by investing activities of $1.3 million was the result of $1.8 million received from dispositions of trading marketable securities offset by $0.5 million from purchases of trading marketable securities

Cash Flows from Financing Activities

During the three months ended March 31, 2025, cash flows provided by financing activities was $0.0 million compared to $0.1 million during the three months ended March 31, 2024. During the three months ended March 31,